Coverage
-
October 14, 2022
Two companies that make rival blood sample analyzers have reached an agreement that will end a patent infringement suit that was scheduled for a jury trial on Nov. 1, the companies told a Delaware federal court Friday.
3 other articles on this case.
View all »